Representatives of Brussels-based offices leading the work of Health Working Group.
ERRIN’s Health Working Group (WG) supports members with early intelligence and regular updates about EU-level health policy-related issues, regulations, EU programmes and their funding opportunities. Creating opportunities for interregional cooperation in the Health area is one of the WG’s main objectives. The WG is also a vehicle for networking, profile raising and promoting good practices and projects among health stakeholders in the ERRIN regions.
The topic of widening gathers high attention in the discussions around the next European Framework Programme for R&I, raising questions with the potential to influence not only the Widening sub-
The Health Working Group meeting will update colleagues on the European Commission’s initiatives linked to staff and skills shortages and training and up-skilling of the health workforce, exploring
ERRIN has been closely involved in the design and implementation of the EU Missions since their inception. Missions remain one of the network's priorities and were one of the four main areas of focus
I2M is gathering digital health leaders to discuss constraints and solutions to successfully adopted innovation for the event 'Successful adoption of healthcare innovation: the active and healthy ageing market'.
Society is challenged by a growing number of ageing people that live longer, age in place and feel lonely. Loneliness is a heterogenic problem. Many interventions have been developed to address loneliness.
There is still a need to realise the potential of personalised medicine to ensure better prevention and care. The ERRIN health meeting will explore existing ecosystems, strategies and initiatives that ensure the development and implementation of personalised medicine for the benefit of the citize
The Co-creating Welfare project was created to serve local welfare services like elderly homes, hospitals and schools, that want to work in a closer dialogue with citizens to co-create future welfare services.
Uptake of Innovation in Hospitals through Skills Development The demographic issue of the ageing society is one of the key challenges facing the European society today.
Flanders Innovation and Entrepreneurship and POM West-Flanders are joining forces to provide policymakers with new tools that can keep our healthcare affordable and sustainable.
The ERRIN Year in review 2022 is out! Read the report to see the numerous activities ERRIN and its members have been involved in throughout the year.
Please find attached ERRIN and the network of European Regional and Local Health Authorities (EUREGHA)'s joint statement on the Horizon Europe Mission on Cancer.
Further to the Health WG meeting on the Cancer Mission, EUREGHA and ERRIN have decided to address the Cancer Mission Board with a statement to emphasise the role of regions in this mission.
On 20 March, the Commission adopted the second Horizon Europe strategic plan. The plan sets out three key strategic orientations for the EU's research and innovation funding for the last three years of the programme (2025-2027). Find out what novelties the new strategic plan brings.
As we enter March and approach the European R&I Days, several ERRIN activities planned for 2024 with a link to FP10 have already taken place, and more are on their way. Have a look at an update with the outcomes of our recent work on the next European Framework Programme for R&I, next steps and opportunities to get involved.
ERRIN is looking for a Communications Assistant! This role is a perfect opportunity to gain first-hand experience in Research and Innovation and participate in the daily work of the organisation. The deadline to apply is 27 February.
The EU-funded project Health InnoFacilitator invites public procurers operational in the provisioning of health and social care to apply for the Call for Coaching Sessions to receive advice to facilitate the launch of future tenders to procure innovative solutions. Coaching will be given on either "Advise public buyers on the formulation of their needs" or "Advise public buyers on the PPI process". The deadline for application is 29 February.
ERRIN is excited to announce the launch of its new Project Development Tool, a significant game-changer in how ERRIN members and their stakeholders engage in project development activities. We encourage all members to log in, explore this tool and leverage it for their project development needs.
Every year ERRIN defines workstreams to guide its work throughout the year, closely linking to its core missions and priorities, as well as the key initiatives in the EU R&I agenda. Discover what has been planned for 2024 in ERRIN Working Groups and Task Forces.
The Joint Programming Initiative (JPI) "More Years, Better Lives is organising an interactive, participatory workshop to discuss with experts what "good care and support” means and what role new technologies play into this notion.
As Belgium moves away from confinement, the ERRIN Secretariat has developed a new work policy with necessary safety measures in line with national guidelines for the coming months.
The European Innovation Council (EIC)'s Accelerator Pilot has awarded €166 million to 36 companies fighting the coronavirus pandemic.
The School of Business, Engineering and Science at Halmstad University invites one or several experienced researchers (has a Ph.D.) of any nationality to develop a collaborative MSCA Individual Fellowship application within the European Commission’s H2020 program. Applicants may not have resided, worked, or studied in Sweden for more than 12 months in the 3 years prior to the call deadline.
Can your region be an example of how the COVID-19 recovery has shifted priorities, putting the green transition and research and innovation at the core of your strategy? We encourage you to get in touch with us as we are looking for regional cases to feed into the policy debate.
The CY-Biobank Center of Excellence in Biobanking and Biomedical Research in Cyprus is looking to be part of a cohort/ consortium under the calls for proposals SC1-PHE-CORONAVIRUS-2020-2D and/or SC1-PHE-CORONAVIRUS-2020-2E.